Prescription drug · ANDA
Acetylcysteine NDC 0517-7504
Acetylcysteine 100 mg/mL · Inhalant · Respiratory (Inhalation) · American Regent, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0517-7504-25 | 0051775042500517750425 | 25 VIAL, GLASS in 1 TRAY (0517-7504-25) / 4 mL in 1 VIAL, GLASSMarketed from Oct 1, 1995 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acetylcysteine
- Generic name (nonproprietary)
- acetylcysteine
- Active ingredients
- Acetylcysteine — 100 mg/mL
- Dosage form
- Inhalant
- Route
- Respiratory (Inhalation)
- Labeler
- American Regent, Inc.NDC labeler code 0517
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 072489
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Respiratory Secretion Viscosity (Physiologic effect)Increased Glutathione Concentration (Physiologic effect)Reduction Activity (Mechanism)
- Identifiers
- Product ID 0517-7504_2bcb9dd3-17f8-439e-a395-aa081c5cc4bfSPL ID 2bcb9dd3-17f8-439e-a395-aa081c5cc4bfSPL set ID f56b4087-db48-4fd7-84ec-9c927962b805RxCUI 307718, 307719UNII WYQ7N0BPYCUPC 0305177510032, 0305177604250, 0305177504253, 0305177610039
- Pharmacologic class
- Antidote; Antidote for Acetaminophen Overdose; Mucolytic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400517750425followed by a unit qualifier and the quantityPackage 00517-7504-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Acetylcysteine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) Pulmonary complications of cystic fibrosis Tracheostomy care Pulmonary complications associated with surgery Use during anesthesia Post-traumatic chest conditions Atelectasis due to mucous obstruction Diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge cath…
Excerpt only. Read the full label for complete information.
About NDC 0517-7504
- What is NDC 0517-7504?
- 0517-7504 is the product NDC for Acetylcysteine, Acetylcysteine 100 mg/mL inhalant, listed with the FDA by American Regent, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Acetylcysteine.
- What is the active ingredient?
- Acetylcysteine.
- Who is the labeler?
- American Regent, Inc., NDC labeler code 0517. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Acetylcysteine?
- 28 other product NDCs are listed under this name. See all Acetylcysteine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Acetylcysteine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Acetylcysteine | Acetylcysteine 200 mg/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9433 | 00143-9433-04 |
| Acetylcysteine | Acetylcysteine 100 mg/mL | SolutionRespiratory (Inhalation) | Cameron Pharmaceuticals | 42494-435 | 42494-0435-25 |
| Acetylcysteine | Acetylcysteine 200 mg/mL | SolutionRespiratory (Inhalation) | Cameron Pharmaceuticals | 42494-436 | 42494-0436-25 |
| Acetylcysteine | Acetylcysteine 100 mg/mL | SolutionRespiratory (Inhalation) | Somerset Therapeutics, LLC | 70069-018 | 70069-0018-25 |
| Acetylcysteine | Acetylcysteine 200 mg/mL | SolutionRespiratory (Inhalation) | Somerset Therapeutics, LLC | 70069-019 | 70069-0019-25 |
| Acetylcysteine | Acetylcysteine 200 mg/mL | SolutionRespiratory (Inhalation) | Somerset Therapeutics, LLC | 70069-020 | 70069-0020-03 |
| Acetylcysteine | Acetylcysteine 200 mg/mL | Injection, SolutionIntravenous | Glenmark Pharmaceuticals Inc., USA | 68462-946 | 68462-0946-12 |
| Acetylcysteine | Acetylcysteine 200 mg/mL | Injection, SolutionIntravenous | Somerset Therapeutics, LLC | 70069-788 | 70069-0788-04 |
| Acetylcysteine | Acetylcysteine 200 mg/mL | Injection, SolutionIntravenous | Xellia Pharmaceuticals USA LLC | 70594-111 | 70594-0111-02 |
| Acetylcysteine | Acetylcysteine 200 mg/mL | Injection, SolutionIntravenous | ONESOURCE SPECIALTY PHARMA LIMITED | 83270-001 | 83270-0001-04 |
Other NDCs under ANDA 072489
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acetylcysteine | Acetylcysteine 100 mg/mL | InhalantRespiratory (Inhalation) | American Regent, Inc. | 0517-7510 |
| Acetylcysteine | Acetylcysteine 100 mg/mL | InhalantRespiratory (Inhalation) | Cardinal Health 107, LLC | 55154-5730 |